First American Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.2M Sell
49,397
-1,226
-2% -$1.25M 3.31% 7
2026
Q1
$46.6M Sell
50,623
-445
-0.9% -$451K 2.92% 7
2025
Q4
$54.9M Sell
51,068
-1,088
-2% -$1.04M 3.33% 7
2025
Q3
$39.8M Sell
52,156
-872
-2% -$649K 2.5% 10
2025
Q2
$41.3M Sell
53,028
-1,673
-3% -$1.3M 2.83% 8
2025
Q1
$45.2M Sell
54,701
-398
-0.7% -$331K 3.34% 6
2024
Q4
$42.5M Sell
55,099
-1,708
-3% -$1.41M 3% 8
2024
Q3
$50.3M Sell
56,807
-3,795
-6% -$3.41M 3.62% 5
2024
Q2
$54.9M Sell
60,602
-975
-2% -$780K 4.11% 4
2024
Q1
$47.9M Sell
61,577
-203
-0.3% -$144K 3.62% 5
2023
Q4
$36M Sell
61,780
-1,866
-3% -$1.09M 3.01% 6
2023
Q3
$34.2M Sell
63,646
-1,523
-2% -$785K 3.09% 5
2023
Q2
$30.6M Sell
65,169
-2,693
-4% -$1.13M 2.65% 8
2023
Q1
$23.3M Sell
67,862
-1,745
-3% -$589K 2.14% 9
2022
Q4
$25.5M Buy
69,607
+2,309
+3% +$819K 2.44% 8
2022
Q3
$21.8M Buy
67,298
+1,974
+3% +$625K 2.27% 8
2022
Q2
$21.2M Sell
65,324
-4,298
-6% -$1.29M 2.16% 10
2022
Q1
$19.9M Buy
69,622
+1,937
+3% +$499K 1.69% 12
2021
Q4
$18.7M Buy
67,685
+2,071
+3% +$525K 0.99% 29
2021
Q3
$15.2M Buy
65,614
+699
+1% +$173K 0.88% 33
2021
Q2
$14.9M Buy
64,915
+3,074
+5% +$617K 0.87% 33
2021
Q1
$11.6M Buy
61,841
+5,148
+9% +$1.01M 0.72% 40
2020
Q4
$9.57M Buy
56,693
+1,397
+3% +$209K 0.64% 44
2020
Q3
$8.18M Sell
55,296
-699
-1% -$108K 0.48% 58
2020
Q2
$9.19M Sell
55,995
-2,220
-4% -$341K 0.58% 48
2020
Q1
$8.08M Buy
58,215
+447
+0.8% +$61.4K 0.6% 43
2019
Q4
$7.59M Buy
+57,768
New +$6.7M 0.48% 64
2019
Q2
$7.36M Buy
66,442
+825
+1% +$97.2K 0.51% 64
2019
Q1
$8.52M Sell
65,617
-10,527
-14% -$1.28M 0.61% 49
2018
Q4
$8.81M Buy
76,144
+2,867
+4% +$320K 0.69% 39
2018
Q3
$7.86M Buy
+73,277
New +$7.33M 0.54% 58
2018
Q1
$5.41M Buy
69,901
+893
+1% +$71.9K 0.41% 71
2017
Q4
$5.83M Buy
69,008
+2,164
+3% +$184K 0.44% 73
2017
Q3
$5.72M Sell
66,844
-9,452
-12% -$775K 0.43% 74
2017
Q2
$6.28M Buy
76,296
+4,553
+6% +$371K 0.5% 59
2017
Q1
$6.03M Buy
71,743
+18,240
+34% +$1.46M 0.49% 60
2016
Q4
$3.94M Sell
53,503
-4,019
-7% -$299K 0.33% 78
2016
Q3
$4.62M Buy
57,522
+1,524
+3% +$122K 0.42% 56
2016
Q2
$4.41M Buy
55,998
+173
+0.3% +$13K 0.42% 53
2016
Q1
$4.02M Buy
55,825
+842
+2% +$63.7K 0.4% 56
2015
Q4
$4.63M Buy
54,983
+1,905
+4% +$158K 0.47% 48
2015
Q3
$4.44M Buy
53,078
+8
+0% +$675 0.49% 47
2015
Q2
$4.43M Sell
53,070
-1,395
-3% -$106K 0.44% 55
2015
Q1
$3.96M Buy
54,465
+783
+1% +$55.7K 0.39% 59
2014
Q4
$3.7M Buy
53,682
+1,012
+2% +$68.3K 0.39% 60
2014
Q3
$3.42M Buy
52,670
+2,506
+5% +$159K 0.37% 63
2014
Q2
$3.12M Sell
50,164
-6
-0% -$358 0.34% 68
2014
Q1
$2.95M Buy
50,170
+1,843
+4% +$103K 0.33% 67
2013
Q4
$2.46M Buy
48,327
+1,290
+3% +$64.6K 0.28% 73
2013
Q3
$2.37M Buy
47,037
+4,550
+11% +$238K 0.29% 69
2013
Q2
$2.09M Buy
+42,487
New +$2.31M 0.29% 67

Other funds holding LLY

First American Bank's LLY Position: Q2 2026 in Review

First American Bank reduced its Eli Lilly (LLY) stake by 2.4% in Q2 2026, selling an estimated $1.25M and leaving 49,397 shares worth $59.2M. The position accounts for 3.31% of the portfolio, ranked #7.

First American Bank first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • First American Bank held 49,397 shares of Eli Lilly worth $59.2M as of Q2 2026.
  • First American Bank sold 1,226 Eli Lilly shares in Q2 2026, an estimated $1.25M.
  • Eli Lilly made up 3.31% of First American Bank's portfolio in Q2 2026, its #7 holding.
  • First American Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on First American Bank's 13F filing for Q2 2026, filed 15 Jul 2026.